https://orcid.org/0000-0002-0597-2728
References
- Hawes R, Fockens P, Varadarajulu S. Endosonography. 4th edn. New York: Elsevier; 2018.
- Kandel P, Wallace MB. Recent advancement in EUS-guided fine needle sampling. J Gastroenterol. 2019;54(5):377–387.
- Rodrigues-Pinto E, Jalaj S, Grimm IS, et al. Impact of EUS-guided fine-needle biopsy sampling with a new core needle on the need for onsite cytopathologic assessment: a preliminary study. Gastrointest Endosc. 2016;84(6):1040–1046.
- Conti CB, Cereatti F, Grassia R. Endoscopic ultrasound-guided sampling of solid pancreatic masses: the fine needle aspiration or fine needle biopsy dilemma. Is the best needle yet to come? World J Gastrointest Endosc. 2019;11(8):454–471.
- Shalabadi M, Gidde STR, Gehret P, et al. Histological evaluation of tissue damage caused by bioinspired needle insertion. Adv Biomater Devices Med. 2018;5:1–6.
- Wang KX, Ben QW, Jin ZD, et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73(2):283–290.
- Oh HC, Kang H, Lee JY, et al. Diagnostic accuracy of 22/25-gauge core needle in endoscopic ultrasound-guided sampling: systematic review and meta-analysis. Korean J Intern Med. 2016;31(6):1073–1083.
- Ishikawa T, Kawashima H, Ohno E, et al. Clinical impact of EUS-guided fine needle biopsy using a novel Franseen needle for histological assessment of pancreatic diseases. Can J Gastroenterol Hepatol. 2019;2019:1–8.
- Yang MJ, Yim H, Hwang JC, et al. Endoscopic ultrasound-guided sampling of solid pancreatic masses: 22-gauge aspiration versus 25-gauge biopsy needles. BMC Gastroenterol. 2015;15:122.
- Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016;48(4):385–402.
- Jang DK, Lee SH. The bleeding risk after endoscopic ultrasound-guided fine needle aspiration in patients taking antithrombotic agents is not negligible. Gut Liver. 2018;12(3):225–226.
- Khan MA, Grimm IS, Ali B, et al. A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy: diagnostic yield and the value of onsite cytopathological assessment. Endosc Int Open. 2017;5(5):E363–E375.
- Early DS, Acosta RD, Chandrasekhara V, et al.; ASGE Standards of Practice Committee. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc. 2013;77(6):839–843.
- Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–454.
- Acosta RD, Abraham NS, Chandrasekhara V, et al.; ASGE Standards of Practice Committee. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16.
- Polmanee P, Hara K, Mizuno N, et al. Outcomes of EUS-FNA in patients receiving antithrombotic therapy. Endosc Int Open. 2019;7(1):E15–E25.
- Kawakubo K, Yane K, Eto K, et al. A prospective multicenter study evaluating bleeding risk after endoscopic ultrasound-guided fine needle aspiration in patients prescribed antithrombotic agents. Gut Liver. 2018;12(3):353–359.
- Hamada T, Yasunaga H, Nakai Y, et al. Severe bleeding and perforation are rare complications of endoscopic ultrasound-guided fine needle aspiration for pancreatic masses: an analysis of 3,090 patients from 212 hospitals. Gut Liver. 2014;8(2):215–218.
- Katanuma A, Maguchi H, Yane K, et al. Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci. 2013;58(7):2093–2099.
- Facciorusso A, Del Prete V, Antonino M, et al. Diagnostic yield of EUS-guided through-the-needle biopsy in pancreatic cysts: a meta-analysis. Gastrointest Endosc. 2020;92(1):1–8.e3.